Kyrgyzstan vs Suriname: Cause of death, by non-communicable diseases, ages 5-14
Kyrgyzstan
36.0%
in 2021
Suriname
37.6%
in 2021
Kyrgyzstan rank
100th
Suriname rank
97th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Kyrgyzstan
- Suriname
How they compare
Suriname currently reports 37.6% against 36.0% in Kyrgyzstan, a difference of 1.6%.
Across all 6 years both countries report, Suriname has been ahead every year.
Kyrgyzstan ranks 100th and Suriname ranks 97th of 185 countries.
Suriname has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.5% | 31.0% | 2.5% | Suriname |
| 2010s | 35.7% | 37.5% | 1.8% | Suriname |
| 2020s | 36.1% | 39.3% | 3.2% | Suriname |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Kyrgyzstan or Suriname?
- Suriname, at 37.6% against 36.0% in Kyrgyzstan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Kyrgyzstan and Suriname?
- 1.6%, with Suriname ahead.
- How many years of comparable data are there for Kyrgyzstan and Suriname?
- 6 years are reported by both, from 2000 to 2021.
- How do Kyrgyzstan and Suriname rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Kyrgyzstan ranks 100th and Suriname ranks 97th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.